I have given up on trying to buy anymore of this in the 30s range.
- Forums
- ASX - By Stock
- LTP
- Ann: Final Patients dosed in SPONTAN pivotal study
LTP
ltr pharma limited
Add to My Watchlist
5.17%
!
27.5¢

Ann: Final Patients dosed in SPONTAN pivotal study, page-68
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.5¢ |
Change
-0.015(5.17%) |
Mkt cap ! $30.78M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.0¢ | $164.5K | 599.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 177053 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 187053 | 0.270 |
6 | 102826 | 0.265 |
8 | 67224 | 0.260 |
3 | 53388 | 0.255 |
7 | 103626 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 7000 | 1 |
0.285 | 71408 | 3 |
0.290 | 8808 | 3 |
0.295 | 31282 | 1 |
0.300 | 42597 | 2 |
Last trade - 10.58am 26/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online